Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication

Table 2

Demographics and clinical characteristics by indication.

Variable	Indication
	Biliary atresia	Hepatoblastoma	Autoimmune cirrhosis	AHN	Metabolic disorders	Percent entry missing
Age (mean)	2.1	2.9	14.7	7.9	6.0	0.0
Male sex (%)	39.6	63.3	32.5	47.3	55.5	0.0
Race and ethnicity (%)
White	48.6	56.7	45.1	42.5	65.0	0.0
Black	17.1	8.4	31.6	16.4	7.6	0.0
Hispanic	21.5	25.1	18.4	32.6	20.7	0.0
Asian American	8.1	5.8	1.9	4.5	5.3	0.0
Other	4.7	4.0	2.9	4.0	1.4	0.0
Height (cm) (mean)	80.7	90.3	157.1	122.5	107.9	28.2
Weight (kg) (mean)	12.8	14.4	58.9	35.4	26.9	28.5
Life support (%)	3.8	4.0	1.9	26.6	4.3	0.0
Dialysis (%)	1.0	1.1	1.0	4.1	2.2	0.0
Insurance (%)
Private	44.5	46.8	55.3	48.2	48.8	0.0
Public	45.1	41.8	38.8	38.9	34.6	0.0
Other form of payment	10.5	11.3	5.8	12.9	16.6	0.0
Status 1 (%)	3.8	38.9	1.9	68.9	11.8	0.0
Status 1A	2.7	2.7	1.5	67.7	10.1
Status 1B	1.0	36.2	0.5	1.1	1.7
Exception submission (%)	50.2	51.0	42.3	6.17	75.4	0.0
Inactive (%)	1.7	1.3	2.9	0.2	0.9	0.0
US citizen (%)	97.4	97.1	99.0	96.8	91.2	0.0
Region (%)
CT, ME, MA, NH, RI	4.4	4.4	1.9	2.7	4.4	0.0
DE, DC, MD, NJ, PA, N. VA, WV	13.5	14.2	12.6	8.9	23.2	0.0
AL, AR, FL, GA, LA, MS, PR	10.4	10.0	19.9	11.3	8.8	0.0
OK, TX	12.3	10.0	17.0	14.3	10.5	0.0
AZ, CA, NV, NM, UT	20.1	23.1	18.4	27.4	17.2	0.0
AK, HI, ID, MT, OR, WA	3.0	2.0	1.9	2.9	2.7	0.0
IL, MN, ND, SD, WI	8.8	6.7	5.3	8.6	12.1	0.0
CO, IA, KS, MO, NE, WY	7.5	9.3	5.3	6.6	6.7	0.0
NY, VT	5.2	5.1	4.4	4.1	5.3	0.0
IN, MI, OH	8.6	10.9	4.4	7.3	6.5	0.0
KY, NC, SC, TN, VA	6.2	4.2	8.7	6.0	2.6	0.0
Blood type (%)
A	32.2	32.9	31.6	30.6	31.0	0.0
B	14.1	11.1	15.0	11.7	14.2	0.0
AB	4.3	3.8	2.9	3.7	4.1	0.0
O	49.4	52.2	50.0	54.0	50.6	0.0
Graft type
Whole cadaveric	42.2	52.0	50.4	38.7	56.8	71.3
Technical variant cadaveric	39.7	33.1	8.7	20.9	25.8	71.3
Live donation	14.0	4.4	4.3	5.3	5.0	71.5